Source: Amedica Corporation
Scorpion(TM) Articulating Inserter Improves Visibility and Access While Reducing Impact on Patient
Amedica Corporation (AMDA),
a company that develops and commercializes silicon nitride ceramics as a
biomaterial platform, is pleased to announce the release of its
Scorpion™ articulating inserter to accompany the Valeo II™ TL interbody
fusion device system. The Scorpion inserter will be commercially
available mid-November 2015, and will aide in minimally-invasive
transforaminal lumbar interbody fusion surgeries.
Scorpion™ articulating inserter
“The TLIF
approach can be particularly complex, requiring superior surgeon
expertise and precision," said Dr. Sonny Bal, chairman and CEO of
Amedica Corporation. "This articulating inserter, used with our Valeo II
TL and Valeo II TL Round systems, offers greater control and placement
accuracy for our silicon nitride interbody fusion device while
performing this minimally-invasive technique. The release of Scorpion
demonstrates our determination to enhance patient care through our
proprietary material and innovative surgical solutions."
The
Valeo II TL and Valeo II TL Round are made of micro composite silicon
nitride biomaterial, which offers a favorable environment for bone
growth and osteointegration, when compared to competitive PEEK and
titanium offerings. Valeo II silicon nitride interbody fusion devices
are also semi-radiolucent with clearly visible boundaries in x-rays and
produce no artifacts under MRI or CT scans. The combination of these
properties is found only in Amedica's silicon nitride biomaterial
technology.
The Valeo II TL is indicated for intervertebral body fusion of the spine in skeletally mature patients and is designed for use with autograft to facilitate fusion. Additional information about Amedica's complete line of products can be found at www.amedica.com.
The Valeo II TL is indicated for intervertebral body fusion of the spine in skeletally mature patients and is designed for use with autograft to facilitate fusion. Additional information about Amedica's complete line of products can be found at www.amedica.com.
About Amedica Corporation
Amedica
is focused on the development and application of medical-grade silicon
nitride ceramics. Amedica markets spinal fusion products and is
developing a new generation of wear- and corrosion-resistant implant
components for hip and knee arthroplasty. The Company manufactures its
products in its ISO 13485 certified manufacturing facility and, through
its partnership with Kyocera, the world's largest ceramic manufacturer.
Amedica's spine products are FDA-cleared, CE-marked, and are currently
marketed in the U.S. and select markets in Europe and South America
through its distributor network and its growing private label and OEM
partnerships.
For more information on Amedica or its silicon nitride material platform, please visit www.amedica.com.
No comments:
Post a Comment